Caring for patients with non-healing wounds is an extremely demanding responsibility. Experimental results indicate that PROTAI︎® possesses remarkable repair capabilities, whether for incisions, burns, or wounds that are challenging to heal, especially in diabetic patients. For individuals with diabetes, the lowered immune function caused by diabetes makes wound healing even more challenging. Therefore, when diabetic patients observe an extended wound healing period, even for minor wounds, prompt and effective treatment is essential. Failure to initiate timely treatment may lead to infection, and in severe cases, it could progress to the point of requiring amputation of the affected limb. Hence, when diabetic patients experience such symptoms, it is crucial to promptly seek appropriate treatment to prevent further complications.
The process of wound healing can be divided into three stages: firstly, clotting and hemostasis, followed by the gathering of white blood cells at the wound site to combat infection.
Finally, it enters the third stage, the proliferation phase. This stage requires the formation of new blood vessels and nerves, thereby promoting the natural generation of new granulation tissue.
PROTAI™ peptide medication has the capability to promote the growth of vascular endothelial growth factor (VEGF),
thereby inducing angiogenesis and effectively facilitating the repair and healing of wounds.
Experimental results confirm that the addition of sequence-specific peptide of PROTAI™
significantlyenhances the process of wound repair and healing.
In terms of promoting normal wound healing,
the efficiency of adding sequence-specific peptides of PROTAI™ reaches as high as 50%.
Simultaneously, for diabetic patients' wound healing,
the addition of sequence-specific peptide of PROTAI™ also demonstrates outstanding effectiveness,
with an efficiency of 25% in promoting healing.
These results indicate that sequence-specific peptide of PROTAI™
has a significant promoting effect on wound repair and healing,
particularly showing remarkable potential applications in both normal and diabetic patients.
美國專利證書ASB0003US號
Patent Location |
Certificate Number |
Name Of The Patent |
USA |
ASB0003US |
Peptide compositions for promoting wound healing and their methods of use |
TAIWAN |
I674276 |
Peptide compositions for promoting wound healing and their methods of use |
TAIWAN |
I754324 |
Short-chain peptide compositions for promoting angiogenesis and their use in the healing of diabetic wounds |
CHINA |
ZL 2017 1 1327924.2 |
Peptides and compositions thereof for promoting wound healing and uses of such peptides |
CHINA |
ZL 2020 1 0787558.4 |
Short-chain peptide for promoting angiogenesis and their use in the healing of diabetic wounds |
